|

PATIENTS NEEDED FOR NEW STUDY
Effects of narrowband UVB phototherapy on melanocyte proliferation in patients with vitiligo
(JCO 0590)
Principal Investigator:
Jules Cohen MD
Investigators:
Contact Information:
Pat Gilleaudeau, FNP
Rockefeller University
1230 York Avenue
New York, NY 10021
|
 |
Telephone: 212-327-8333
FAX: 212-327-8232
Email: gilleap@rockefeller.edu |
Contact Information:
Enrollment Status:
Open to Enrollment
Brief Summary of Protocol:
Narrowband UVB (NBUVB) phototherapy light treatment three times a week for 6 months. Skin biopsies will be done before treatment and twice during treatment. A total of 6 skin biopsies will be done.
Detailed Description of Protocol:
All patients will receive phototherapy, with narrowband UVB, three times a week for six months, or a total of 78 treatments. 6mm punch skin biopsies (2) will be done prior to starting therapy, once during treatment (2) and at the completion of the study (2). Clinical assessments and photography will be done parallel to the skin biopsies. Results (clinically and histologically) will be analyzed.
Profile:
18 years and older with vitiligo
What specifically makes a person eligible for the study?
You may be eligible to enter this study:
5% or more body surface are involved with vitiligo
Gender:
Both
Age(s):
18 years and older
Children permitted to participate:
No
Potential Benefits.....
Free treatment
Contribute to the knowledge about the disease
Compensation:
None
Back To The Vitiligo Research Page
|